Powered by Business Wire
Biotechnology Headlines

Elekta: Welcome to Elekta’s Capital Markets Day at ASTRO

STOCKHOLM--(BUSINESS WIRE)--Elekta (STO:EKTAB)

Elekta welcomes you to its Capital Markets Day on September 15, in conjunction with the 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO), in San Francisco, USA.

The event will be held on Monday, September 15, at 09:00 am – 11:30 am local time, at Marriott Marquise Hotel, 780 Mission Street. Breakfast will be served.

Speakers at this event will be Niklas Savander, Elekta’s President and CEO and other members of Elekta’s management team.

It will also be possible to listen to the presentations over the phone and via the web.Please use the following link:

http://event.onlineseminarsolutions.com/r.htm?e=841292&s=1&k=11D0843436D4297552CAA722BE1F5E28

Telephone numbers:

· Sweden: +46 8 505 964 04

· UK: +44 203 147 4824

· USA: +1888 424 8151

Passcode: 6825094

Investors who want to attend the Capital Market Day are kindly requested to give notice by e-mail to elisabeth.natt.och.dag@elekta.com before September 5.

Additional Elekta events at ASTRO

Investors are also welcome to participate in:

The Elekta Oncology Users Meeting (EOUM) held on Saturday, September 13, at 09:00 am – 10:30 am, at Moscone Center, North Hall, 747 Howard Street, San Francisco. To register please use this link: www.elekta.com/eoum.

A guided Elekta Booth Tour arranged on Monday, September 15, starting at 13:00 pm. Investors who want to attend the Booth Tour are kindly requested to give notice by e-mail to elisabeth.natt.och.dag@elekta.com before September 5.

We look forward to your participation on September 15.

Best regards,

Johan Andersson

Director Investor Relations

Tobias Bülow

Director Financial Communication

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.

This information was brought to you by Cision http://news.cision.com

Contacts

Elekta AB
Elisabeth Natt och Dag
Information Manager
Tel: +46 733 16 16 88
e-mail: elisabeth.natt.och.dag@elekta.com